InvestorsHub Logo
Followers 10
Posts 1734
Boards Moderated 1
Alias Born 10/08/2011

Re: jackcross18 post# 37007

Saturday, 10/18/2014 11:44:54 AM

Saturday, October 18, 2014 11:44:54 AM

Post# of 52074
jackross correct me if I am wrong, but doesn't mzei have the most expensive opex and is time consuming and requires more labor, so that is what I mean by cb study being useful to sell it. Every health region has different parameters so generalizing is not prudent however it's safe to say the first thing that budget constrained hospitals look at is opex although other factors are obviously at play for different products if you have something concrete to argue your product is the best choice in Cda. For instance, the number one silver bandage sold worldwide ($4B market overall) is not the most efficacious or even close, but is the cheapest. I think it is Seasorb by Coloplast (in a study using FDA standards at .64 log scale microbe kill it has less than 100 fold reduction of Candida!) but could be Aquacel by Convatec.
I actually just quickly skimmed your post (and erroneously assumed the post was about someone else's product) for my response last night that has fortunately been deleted, and not being around here in 2013 didn't know they had a marketing deal in 2013 that has so far flopped.
For the other part of your question, it would take a lot of explaining from someone at mgmt about what went wrong, rather than the 2 of us debating if everyone in Cda is stupid as your post asks."Is everyone in Canada stupid ?"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.